The food system is entering a phase in which innovation is no longer optional. It is becoming a structural necessity.
Population growth, pressure on natural resources, climate instability, changing consumer expectations and the rising demand for functional ingredients are forcing the food industry to rethink not only what we eat, but how key nutrients and bioactive compounds are produced.
For many years, food innovation was mainly associated with new formulations, processing methods, packaging, branding or consumer experience. Today, the challenge is deeper. The industry needs new biological platforms capable of producing proteins, pigments, omega-3, antioxidants and other functional compounds in a way that is more sustainable, scalable and traceable.
This is where microalgae are attracting growing attention.
Microalgae are among the most promising biological resources for the future of food, feed and health. They can produce high-quality proteins, omega-3 fatty acids, carotenoids, natural pigments, antioxidants and several other high-value molecules. Their potential applications range from nutraceuticals and functional foods to aquaculture, pet food, cosmetics and natural colorants.
In nature, microalgae are the original source of many compounds that later accumulate through the marine food chain. Omega-3, carotenoids, proteins and other bioactive molecules often originate from primary producers before reaching fish, crustaceans or other marine organisms. From this perspective, microalgae offer a simple but powerful idea: instead of extracting valuable compounds and nutrients from animals or wild marine resources, we can produce them directly from the biological source.
This is particularly relevant not only for high-value bioactives, but also for proteins. Microalgae can provide high-quality proteins (50-60% of weight) without relying on arable land, while reducing pressure on traditional agricultural and marine resources.
However, this potential has often been communicated in an oversimplified way.
Microalgae are not a magic solution. They are not automatically sustainable, cheap or scalable just because they are photosynthetic organisms. The real challenge is not only to grow microalgae, but to make them productive, standardized, cost-competitiveand suitable for real industrial applications.
This is why innovation is no longer optional.
The microalgae sector has historically faced several bottlenecks. Productivity can be too low for many commodity applications. Cultivation systems may require significant capital expenditure. Downstream processing and extraction can represent a large share of production costs. Biomass composition can vary depending on strain, light, nutrients, temperature and process conditions. Regulatory pathways can be complex, especially for food and feed applications. Finally, many products have lacked a clear market positioning: they have been presented simply as “algae” rather than as precise solutions to specific industrial problems.
The next generation of microalgae companies will need to move beyond generic biomass production. The future of the sector will depend on proprietary strains, improved productivity, targeted molecules, simpler extraction processes, validated applications and scalable industrial models. In other words, the value will not come only from cultivating microalgae, but from transforming microalgal biodiversity into standardized and functional ingredients.
This shift is particularly important in health-oriented markets.
Consumers are increasingly looking for natural, traceable and science-based ingredients that support wellbeing, prevention and healthy ageing. Carotenoids such as lutein, zeaxanthin and astaxanthin are gaining attention for their antioxidant properties and their potential role in areas such as eye health, skin health and healthy ageing. Omega-3 fatty acids remain essential for cardiovascular and metabolic wellness. Natural pigments are increasingly demanded as alternatives to synthetic colorants. At the same time, companies need reliable sources that can be produced with quality, consistency and sustainability.
Microalgae can address these needs, but only if innovation closes the gap between biological potential and industrial reality.
Natural astaxanthin from microalgae is a good example. It is a high-value carotenoid with strong market interest, but its cost and production complexity limit its use in large-volume applications. Synthetic astaxanthin is widely used where price and standardization are critical, such as aquaculture, but it does not match the growing demand for natural, traceable and sustainable ingredients and cannot be used as human supplements. Making natural carotenoids more accessible requires better strains, higher productivity and more efficient downstream processes.
The same applies to omega-3. Marine omega-3 traditionally depends on fish oil and other marine resources, exposing supply chains to price volatility, availability constraints and sustainability concerns. Microalgae represent the original biological source of these molecules, but producing them competitively at scale requires technological progress in cultivation, harvesting, processing and formulation.
This is the core point: microalgae will not succeed only because they are natural or sustainable. They will succeed when they solve specific problems better than existing alternatives.
The opportunity is not one single market. The opportunity is a platform.
Microalgae can become a flexible biological platform for the production of multiple bioactive ingredients across food, feed, cosmetics and health-related industries. But to unlock this potential, the sector must evolve from promise to execution. Scientific excellence must be connected to industrial scale-up.
This is where companies emerging from strong research backgrounds can play an important role.
Asteasier is an example of this transition from academic research to industrial application. Born as a spin-off of the University of Verona, the company develops proprietary microalgae-based technologies to produce natural bioactive ingredients for human and animal health. Its approach is not simply to produce algal biomass, but to generate functional ingredients with defined applications, such as carotenoid-rich ingredients for human nutrition and multifunctional microalgal biomasses for aquafeed and pet food.
The logic reflects the broader evolution needed in the sector: microalgae must move from being perceived as a promising raw material to becoming a source of validated, scalable and market-ready ingredients.
Innovation in food is no longer about novelty for its own sake. It is about building resilient supply chains, reducing pressure on natural resources, improving nutrition and creating products that combine performance, sustainability and consumer trust.
Microalgae can be one of the most powerful tools in this transformation. But their future will depend on the ability to make them productive, affordable, standardized and truly useful.
The question is no longer whether microalgae have potential. The real challenge is turning that potential into validated, scalable and market-ready products. And this is already happening: the next generation of microalgae innovation is moving beyond research, transforming biological potential into real ingredients, real markets and real impact.
